BLTE · Belite Bio Inc ADR
United States · RS rating 52 · As of 2026-10-14
| Price | 152.72 USD |
|---|---|
| 1-day change | +0.6% |
| RS rating (overall / 1M / 3M / 12M) | 52 / 23 / 70 / 94 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 37 / 41 / 17 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -7.7% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +21.1% |
| Market cap (USD) | $6.6B |